|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.60 EUR | +0.80% |
|
+10.42% | +5.49% |
| 06-15 | Kerry Group Director Fiona Dawson buys GBP148,519 shares | AN |
| 05-11 | Bio-K+ Advances Research on Gut Health and Autism Spectrum Disorder with Clinical Study Findings | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- KRZ Stock
- KRZ Stock
- Consensus Kerry Group plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
